New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately t...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Scientists Successfully Attached a Pig Kidney to Human For the First Time
Scientists temporarily attached a pig’s kidney to a human body and watched it begin to work, a small step in the decades-long quest to one day use animal organs for life-saving transplants. Pigs have been the most recent research focus to address the organ shortage, but among the hurdles: A sugar in pig cells, foreign to the human body, causes immediate organ rejection. The kidney for this experiment came from a gene-edited animal, engineered to eliminate that sugar and avoid an immune system attack. Surgeons attached the pig kidney to a pair of large blood vessels outside the body of a deceased recipient so they cou...
Source: TIME: Health - October 20, 2021 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Research wire Source Type: news

Scientists Successfully Attached a Pig Kidney to Human For the First Time
Scientists temporarily attached a pig’s kidney to a human body and watched it begin to work, a small step in the decades-long quest to one day use animal organs for life-saving transplants. Pigs have been the most recent research focus to address the organ shortage, but among the hurdles: A sugar in pig cells, foreign to the human body, causes immediate organ rejection. The kidney for this experiment came from a gene-edited animal, engineered to eliminate that sugar and avoid an immune system attack. Surgeons attached the pig kidney to a pair of large blood vessels outside the body of a deceased recipient so they cou...
Source: TIME: Science - October 20, 2021 Category: Science Authors: Carla K. Johnson / AP Tags: Uncategorized Research wire Source Type: news

Mothers of premature babies 'are more than TWICE as likely to develop high blood pressure'
A study, of more than 2million women in Sweden, found mothers of premature babies had a greater risk of high blood pressure, a key factor in heart disease, within 10 years after birth. (Source: the Mail online | Health)
Source: the Mail online | Health - October 13, 2021 Category: Consumer Health News Source Type: news

Aspirin use to prevent 1st heart attack or stroke should be curtailed, US panel says
The U.S. panel also plans to retreat from its 2016 recommendation to take baby aspirin for the prevention of colorectal cancer, guidance that was groundbreaking at the time. The panel said that more recent data had raised questions about the putative benefits for cancer, and that more research was needed. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 12, 2021 Category: Pharmaceuticals Source Type: news

Janssen Submits Application Seeking U.S. FDA Approval of STELARA ® (ustekinumab) for the Treatment of Pediatric Patients With Juvenile Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, October 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking expanded approval of STELARA® (ustekinumab) to treat pediatric patients ages 5 years and older with juvenile psoriatic arthritis (jPsA).The filing is supported by extrapolation of data from nine studies across both adult trials in active PsA and adult and pediatric studies in moderate to severe plaque psoriasis, totaling 3,997 patients evaluated across these closely associa...
Source: Johnson and Johnson - October 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Mayo Clinic Q and A: Pregnancy and the heart
DEAR MAYO CLINIC: I am ready to start a family, but my doctor said that pregnancy may be high-risk for me because I have a heart condition. Can you explain how pregnancy affects the heart and what I can do to lower my risk for complications? ANSWER: Pregnancy results in many changes that can increase the workload of the heart. During pregnancy, your blood volume increases by 30% to 50% to nourish your growing baby, your heart… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 8, 2021 Category: Databases & Libraries Source Type: news

New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA ® (ustekinumab) in Older Patients Across Approved Indications
SPRING HOUSE, PENNSYLVANIA, October 4, 2021 – Today, the Janssen Pharmaceutical Companies of Johnson & Johnson announced a new analysis of STELARA® (ustekinumab) pooled safety data from 13 clinical studies across approved indications, showing rates of key safety events among adults 60 years and older treated with STELARA for up to five yearsa were similar to rates observed with placebo during the control phase of these trials.1,b Approved indications included adults with moderately to severely active Crohn’s disease (CD), moderately to severely active ulcerative colitis (UC), moderate to severe plaque p...
Source: Johnson and Johnson - October 4, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO ® (rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related Events
RARITAN, NJ, September 27, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data from the Phase 3 UNIVERSE study showing treatment with XARELTO® (rivaroxaban) in an oral suspension formulation, compared to treatment with aspirin, was associated with numerically fewer blood clots and clinical events strongly associated with blood clots in pediatric patients (aged 2-8 years) who have undergone the Fontan procedure. [1] These findings, which were published this month in the Journal of the American Heart Association and included in a recent New Drug Application submitted to the...
Source: Johnson and Johnson - September 27, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

What Looks Like Acrocyanosis?
Discussion Acrocyanosis is a peripheral vascular disease where the skin and mucous membranes have a persistent, painless, deep-bluish color due to decreased oxygenated blood which usually is benign. The deoxygenated blood can be due to a central cause such as cyanotic congenital heart disease or localized problems often due to vasospasm. Hands and feet are the most common areas affected. It is thought that there is “…vasospasm of the cutaneous arteries, and arterioles along with compensatory dilatation in the capillary and post capillary venules caus[ing] cyanosis and sweating.” Palms and soles may or ma...
Source: PediatricEducation.org - September 27, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

KJ Apa Is a Dad! Riverdale Star and Model Clara Berry Welcome First Baby
"I am the luckiest to have now two men of my life, filling my heart with this cosmic gigantic vast love," Berry wrote announcing the... (Source: Reuters: Health)
Source: Reuters: Health - September 26, 2021 Category: Consumer Health News Source Type: news

Breastfeeding May Strengthen a Baby's Heart
This study … adds to the already known benefits of breast milk for infants born prematurely, " said study leader Dr. Afif El-Khuffash, a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 6, 2021 Category: General Medicine Source Type: news

Janssen Announces U.S. FDA Approval of INVEGA HAFYERA ™(6-month paliperidone palmitate), First and Only Twice-Yearly Treatment for Adults with Schizophrenia
TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic INVEGA HAFYERA™ (6-month paliperidone palmitate), the first-and-only twice-yearly injectable for the treatment of schizophrenia in adults. Before transitioning to INVEGA HAFYERA™, patients must be adequately treated with INVEGA SUSTENNA® (1-month paliperidone palmitate) for at least four months, or INVEGA TRINZA® (3-month paliperidone palmitate) for at least one 3-month injection cycle.1 The FDA a...
Source: Johnson and Johnson - September 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

When Will COVID-19 Vaccines Be Available for Younger Kids?
As the school year gets underway and the Delta variant continues its march through the U.S. population, many parents with kids younger than 12 have the same question: When will vaccines become available for my child? No one knows exactly when the U.S. Food and Drug Administration (FDA) may grant one or multiple COVID-19 vaccines emergency-use authorization for children younger than 12. But Dr. Robert Frenck, director of the Vaccine Research Center at Cincinnati Children’s Hospital Medical Center and one of the investigators involved in testing Pfizer-BioNTech’s shot in kids, guesses parents will have to wait at...
Source: TIME: Health - August 30, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Slain Marine who cradled baby at Kabul airport loved her job
Heart-wrenching details have emerged about some of the 13 U.S. troops killed in a horrific suicide bombing at Afghanistan’s Kabul... (Source: Reuters: Health)
Source: Reuters: Health - August 28, 2021 Category: Consumer Health News Source Type: news

FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) e...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

AHA News: Son's Scary Heart Defect Led Couple to Help Other Parents
TUESDAY, Aug. 17, 2021 (American Heart Association News) -- Linda and Clint Pilkinton had a healthy toddler when Linda got pregnant with their second child. They were eager to give Charlie a baby brother. The first trimester of her pregnancy... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 17, 2021 Category: General Medicine Source Type: news

Race-based aborted baby-parts operations reminiscent of Kermit Gosnell scandal
(Natural News) Various abortion programs at the University of Pittsburgh have been getting the school slammed in recent days, with accusations it assembled a tissue bank holding hearts, legs and brains from unborn babies who were cut up and stored. (Article by Bob Unruh republished from WND.com) But one of the more horrific accusations has now... (Source: NaturalNews.com)
Source: NaturalNews.com - August 16, 2021 Category: Consumer Health News Source Type: news

DR Congo, Ituri. Fleeing War, Weaving Life in IDP Camps of Bunia
The man reading is a displaced man in the IDP camp ISP in Bunia. Credit: Elena L. Pasquini By Elena L. PasquiniROME, Jul 29 2021 (IPS) He moves aside the curtain, thin as gauze, and then bends over. The darkness dazzles for a few seconds when one enters the house—actually, a den made of earth where air and light filter through the narrow entrance. Jean de Dieu Amani Paye holds her tiny baby, wrapped in an elegant fabric, in his arms. He was a teacher of French and Latin and had a small business. He also cultivated the land: cassava, corn, sorghum, and beans. Now he is a leader of the ISP camp on the outskirts of Bun...
Source: IPS Inter Press Service - Health - July 29, 2021 Category: International Medicine & Public Health Authors: Elena Pasquini Tags: Africa Aid Armed Conflicts Crime & Justice Featured Gender Violence Headlines Health Human Rights Humanitarian Emergencies Migration & Refugees TerraViva United Nations Women's Health Source Type: news

AHA News: She Had a Baby. Then Emergency Heart Surgery. And a Stroke. Then, a New Heart.
THURSDAY, July 29, 2021 (American Heart Association News) -- In her third trimester, Kristy Novillo struggled to give tours of the Redmond, Washington, child care center where she worked as a director. Walking and talking at the same time left her... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 29, 2021 Category: General Medicine Source Type: news

Shortages Reveal Low Priority of Women ’s Health in Nepal
Chiring Tamang holds the family’s new baby while his wife Priya looks on. She delivered the girl at home in their village in Nepal’s Sindhupalchowk district in February 2021. Credit: Marty Logan / IPSBy Marty LoganKathmandu, Nepal, Jul 21 2021 (IPS) One year after Nepal’s Ministry of Health (MoH) appealed to international organisations in the country to urgently supply a drug used to stop excessive bleeding after childbirth, a UN agency has delivered $1 million worth of contraceptives to prevent another shortage. The 1.6 million cycles of oral contraceptive pills and 776,000 units of injectable contracep...
Source: IPS Inter Press Service - Health - July 21, 2021 Category: International Medicine & Public Health Authors: Marty Logan Tags: Asia-Pacific COVID-19 Featured Gender Headlines Health Human Rights Humanitarian Emergencies Inequity TerraViva United Nations Women's Health contraceptives UNFPA United Nations Population Fund (UNFPA) Source Type: news

AHA News: Pregnant Mom's Diet May Influence Baby's Cardiovascular Health
MONDAY, July 19, 2021 (American Heart Association News) -- A pregnant woman's diet and other lifestyle factors may change how her baby's genes work in a way that can affect the child's cardiovascular health by age 8 or 9, new research has... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 19, 2021 Category: General Medicine Source Type: news

Hope, horror and Covid-19: my 23 years as the Guardian ’s health correspondent | Sarah Boseley
I ’ve travelled the world covering everything from HIV to MMR to Ebola… and then Covid came along. These are stories that changed me – and the worldShe was tall, wrapped in a green patterned dress that clung to her legs and ended just above dusty flip-flops. In the bustling, sweltering market, Grace Mathanga looked at me appraisingly, as if to say: “What have we here?” And I knew she was the one.It was the end of2002. I had flown to Lilongwe, the capital of Malawi, with excitement in my heart and fear of failure eating at my gut. I ’d been the Guardian’s health correspondent for a...
Source: Guardian Unlimited Science - July 17, 2021 Category: Science Authors: Sarah Boseley Tags: Health Coronavirus Aids and HIV Infectious diseases Vaccines and immunisation Society Ebola Africa Epidemics World news Global health Global development Campaigning journalism Newspapers & magazines Media Source Type: news

New research aims to improve treatments and outcomes for people with severe asthma
(Cleveland Clinic) A new phase 2 clinical trial of multiple therapies for severe asthma is underway in Northeast Ohio, with a focus on personalized therapies based on genetics, family history, lifestyle and environmental factors.The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE) study, sponsored by the National Heart, Lung and Blood Institute (NHBLI), is enrolling patients at Cleveland Clinic and University Hospitals Rainbow Babies& Children's Hospital. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2021 Category: International Medicine & Public Health Source Type: news

STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
SPRING HOUSE, PENNSYLVANIA, July 9, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new three-year data from the long-term extension (LTE) of the STELARA® (ustekinumab) Phase 3 UNIFI study. The data demonstrated the majority (55.2 percent) of adult patients with moderately to severely active ulcerative colitis (UC) who initially responded to treatment with STELARA sustained symptomatic remissiona rates at nearly three years (week 152).1 Furthermore, a majority (96.4 percent) of the patients in symptomatic remissiona at week 152 were corticosteroid-free. These data are being pr...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Featured review: Low-dose misoprostol given by mouth for induction of labour
First author of this new Cochrane Review,' Low ‐dose oral misoprostol for induction of labour', Robert Kerr explains, “Our review found that Misoprostol given orally outperforms the ‘gold-standard’ drug which is much more expensive, and used in preference in many countries. This review has the potential to impact millions of women and babies who have inductions of labour through its comparison of oral misopro stol with other commonly used induction techniques. " Labour inductions are common around the world. Induction rates vary worldwide, but for example in the UK, 1 in 3 women will have labo...
Source: Cochrane News and Events - June 28, 2021 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with co...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Too Many Older Americans Are Taking Daily Aspirin
TUESDAY, June 22, 2021 -- Many older adults are still taking a daily baby aspirin to ward off first-time heart problems— despite guidelines that now discourage it, a new study finds. Researchers found that one-half to 62% of U.S. adults aged... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 22, 2021 Category: General Medicine Source Type: news

AHA News: Preterm Babies May Have Higher Stroke Risk as Young Adults
Title: AHA News: Preterm Babies May Have Higher Stroke Risk as Young AdultsCategory: Health NewsCreated: 6/17/2021 12:00:00 AMLast Editorial Review: 6/18/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 18, 2021 Category: Cardiology Source Type: news

AHA News: Preterm Babies May Have Higher Stroke Risk as Young Adults
THURSDAY, June 17, 2021 (American Heart Association News) -- Babies born prematurely may have significantly higher risk of stroke as young adults– and the earlier the birth, the greater the risk, suggests an extensive new study. Although... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 17, 2021 Category: General Medicine Source Type: news

Almost 25% of COVID-19 Patients Develop Long-Lasting Symptoms, According to a New Report
A year and a half into the pandemic, the condition known as Long COVID continues to stump doctors. A significant number of patients develop long-term symptoms after catching COVID-19, but it hasn’t been clear why that happens, who is likely to get sick or even how many people continue to suffer. A large new study may help form some answers to those questions. In line with prior estimates, it finds that almost a quarter of people infected with the virus develop at least one lingering health problem, and that most Long COVID symptoms are more commonly reported by women than men. [time-brightcove not-tgx=”true&rdq...
Source: TIME: Health - June 15, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

‘A Year Full of Emotions.’ What Kids Learned From the COVID-19 Pandemic
Too many young generations have been shaped by the global crises they faced—Depression-era poverty, Cold War nuclear fears. Add to them the COVID generation. The virus itself may typically go easier on kids than it does adults, but the mind of a child is another thing. It’s dependent on certainty, safety, the comfort of routine. Take all of that away—shutter schools, keep grandparents at a distance, cancel summer camps—and kids suffer. But as the following lightly-edited stories from young people show, they also grow and learn, gain maturity and wisdom. The virus has been tough; plenty of kids, it t...
Source: TIME: Health - June 12, 2021 Category: Consumer Health News Authors: Jeffrey Kluger and Allison Singer Tags: Uncategorized COVID-19 Source Type: news

New Phase 3b Psoriatic Arthritis (PsA) Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Robust Joint Symptom Improvement and Complete Skin Clearance in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)
SPRING HOUSE, PENNSYLVANIA, June 2, 2021 – Today the Janssen Pharmaceutical Companies of Johnson & Johnson announced new efficacy and safety data for first-in-class TREMFYA® (guselkumab), including data from the first study evaluating a selective IL-23 inhibitor in adult patients with active PsA, all of whom had demonstrated inadequate response or intolerance to TNFi.1 In the COSMOS Phase 3b study, significantly higher proportions of patients treated with TREMFYA showed joint symptom improvement and complete skin clearance versus placebo at week 24 in this true TNFi-IRa patient population, which is often more...
Source: Johnson and Johnson - June 2, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

UCLA Health clinic helps mom heal after near-death birth experience
Marisa Peters, a 38-year-old mom of three, expected the delivery of her third child to be ordinary and uneventful, just like the births of her two other children. But right after her water broke at Ronald Reagan UCLA Medical Center on Feb. 6, 2019, she became quickly aware that this delivery would be very different.The first sign was a high fever that escalated rapidly. Then she developed an infection and began experiencing full-body convulsions, which were followed by a painful singular contraction that lasted for one hour. During this time, the baby ’s heart rate dipped, but she was lucky to catch a small window of...
Source: UCLA Newsroom: Health Sciences - May 26, 2021 Category: Universities & Medical Training Source Type: news

Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn ’s Disease
SPRING HOUSE, PENNSYLVANIA, May 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohn’s disease (CD) and ulcerative colitis (UC),1-4including data from the SEAVUE study, the first head-to-head study of biologic therapies in patients with CD, presented in a Clinical Science Late-Breaking Abstract Plenary session.1 SEAVUE data showed treatment with STELARA demonstrated high rates of clinical remission, corticosteroid-free remission, clinical response and endoscopic response through one year in biologic-naïve p...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

AHA News: A Baby's Gut Bacteria May Predict Future Obesity
THURSDAY, May 20, 2021 (American Heart Association News) -- New research into the growing problem of early childhood obesity suggests the bacteria in a baby's gut may indicate weight problems in the years to come. Researchers examined gut microbiota... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 20, 2021 Category: General Medicine Source Type: news

Late-Breaking Data at ACC.21 Show XARELTO ® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization
RARITAN, N.J., May 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced severe vascular events in patients with peripheral artery disease (PAD) after lower-extremity revascularization (LER) compared to aspirin alone regardless of whether it was the first, second, third, or subsequent event. The primary results of VOYAGER PAD showed that XARELTO® plus aspirin reduced first events by 15 percent among patients...
Source: Johnson and Johnson - May 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

AHA News: Preterm Deliveries May Pose Long-Term Stroke Risk for Mothers
MONDAY, May 10, 2021 (American Heart Association News) -- It's not surprising that babies born prematurely may face more health issues than those who were carried to term. But new research suggests the same may apply to their mothers. A study... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 10, 2021 Category: General Medicine Source Type: news

Genetically Modified Mosquitoes Have Come to the U.S. Will They Work?
“Our Mosquito Project Takes Flight,” reads a baby-blue billboard off US-1 in the Florida Keys, alongside an image of an insect tracing a path in the shape of a heart. Sponsored by the local mosquito control board and U.K.-based biotech firm Oxitec, the ad promotes a contentious plan to release millions of genetically modified Aedes aegypti mosquitoes here to test a new method of bioengineered pest control. It’s the first-ever such experiment in the United States, and one that has turned this chain of sun-soaked island communities into a battleground over scientific truth, government authority, and humanit...
Source: TIME: Health - May 9, 2021 Category: Consumer Health News Authors: Alejandro de la Garza / Florida Keys, Fl. Tags: Uncategorized Source Type: news

Researchers describe rare case of heart rhythm problem in newborn with Turner syndrome
(Boston University School of Medicine) Doctors treating babies born with Turner syndrome need to look for heart rhythm abnormalities, in addition to the usual heart problems of high blood pressure or left-sided structural heart defects, according to Meena Bolourchi, MD, assistant professor of pediatrics at Boston University School of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 30, 2021 Category: International Medicine & Public Health Source Type: news

New Phase 3 Data Showed First-in-Class TREMFYA ® (guselkumab) Provided Durable Complete Skin Clearance Through Five Years in Moderate to Severe Plaque Psoriasis (PsO) and Robust Joint Symptom Improvement Through 52 Weeks in Active Psoriatic Arthritis (PsA)
SPRING HOUSE, PENNSYLVANIA, April 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new Phase 3 data which showed TREMFYA® (guselkumab) sustained durable, complete skin clearance rates in a majority of adults with moderate to severe plaque psoriasis (PsO) through five years (252 weeks), a and improved disease activity and axial symptoms in adults with active psoriatic arthritis (PsA) through one year (52 weeks).1,2,3 These data are being presented at the American Academy of Dermatology Virtual Meeting Experience 2021, where Janssen will present a total of 22 abstracts. TREMF...
Source: Johnson and Johnson - April 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Johnson & Johnson Reports 2021 First-Quarter Results
New Brunswick, N.J. (April 20, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2021. “Johnson & Johnson delivered a strong first quarter performance led by the above market growth of our Pharmaceutical business and continued recovery in Medical Devices,” said Alex Gorsky, Chairman and Chief Executive Officer. “The ability to deliver these results while simultaneously advancing our robust pipeline of life-enhancing medicines, products and solutions during these times is a testament to the strength and resilience of our business and the dedication of the 135,000...
Source: Johnson and Johnson - April 20, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

'Baby, that's the police': Woman in SUV said cop came to window with gun drawn
Defense attorney Eric Nelson has contended that George Floyd died from serious heart problems combined with illicit drug use, rather... (Source: Reuters: Health)
Source: Reuters: Health - April 13, 2021 Category: Consumer Health News Source Type: news

Aaliyah ’s mother reacts to DMX’s death: ‘You and baby girl will meet again’
‘Earl, you had and still have a heart of gold’ (Source: Reuters: Health)
Source: Reuters: Health - April 9, 2021 Category: Consumer Health News Source Type: news

Stethoscope Remains Best Way to Monitor Fetal Distress During Labor
WEDNESDAY, April 7, 2021 -- Listening to a fetal heart rate using a stethoscope is still the best method for determining whether a baby is in distress during delivery, according to a review published online April 6 in CMAJ, the journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 7, 2021 Category: Pharmaceuticals Source Type: news

Reproduction without pregnancy: would it really emancipate women? | Jenny Kleeman
It may sound far-fetched, but a breakthrough in Israel has brought us a step closer to creating artificial wombs for humansA team of Israeli scientists announced the mother of all inventions last week. Researchers from the Weizmann Institute of Science revealedin the journal Nature that they had successfully gestated hundreds of mice inside an artificial womb. They placed newly fertilised eggsinside glass vials rotating in a ventilated incubator, and grew the embryos for 11 days – the mid-point of a mouse pregnancy – outside their mothers’ bodies. The embryos developed normally; their hearts, visible thro...
Source: Guardian Unlimited Science - March 25, 2021 Category: Science Authors: Jenny Kleeman Tags: Reproductive rights Reproduction Science Health Fertility problems Society Parents and parenting Women World news Source Type: news

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profi...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

New Phase 3 Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Complete Skin Clearance and Favorable Joint Efficacy in Adult Patients with Active Psoriatic Arthritis (PsA) Through Two Years
SPRING HOUSE, PENNSYLVANIA, March 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced long-term data from the Phase 3 DISCOVER-2a study showing that the skin clearance, joint symptom relief, and safety of TREMFYA® (guselkumab) previously demonstrated through 24 weeks and one year (Week 52) in adults with active psoriatic arthritis (PsA) continued through two years (Week 112).1,2 These findings also confirmed that the robust efficacy TREMFYA demonstrated in patients at Week 24 on physical function, physical aspects of health-related quality of life, and resolution of enthesitis...
Source: Johnson and Johnson - March 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Does aspirin thin the blood? How much aspirin you should take - and when it can be harmful
ASPIRIN is a common painkiller that's usually used for headaches, flu, toothaches, and even fevers. But does aspirin thin the blood? Here's why 'baby aspirin' may be used to prevent heart attacks and strokes - and the amount of aspirin you should have to avoid harmful side-effects. (Source: Daily Express - Health)
Source: Daily Express - Health - March 12, 2021 Category: Consumer Health News Source Type: news

We read books to my daughter from birth, which enriched all our lives
A difficult pregnancy meant the only item I dared buy for my unborn child was a book. When she arrived we read it to her every dayNine years ago, I gave birth to a little girl. And now that little girl has grown into abookworm. It began, as all stories about books should really begin, in a bookshop. I was several months pregnant and I picked up an American picture book I had never come across before:Goodnight Moon by Margaret Wise Brown. It featured a poem that my husband and I would end up reading, oh, I don ’t know, at least 900 times. The book became such a pillar of my daughter’s nightly routine that by the...
Source: Guardian Unlimited Science - March 6, 2021 Category: Science Authors: Donna Ferguson Tags: Children's books: 7 and under Pregnancy Parents and parenting Family Life and style Psychology Science Health & wellbeing Source Type: news